Navigation Links
Lockheed Martin Completes Acquisition of QTC Holdings Inc.
Date:9/27/2011

BETHESDA, Md., Sept. 27, 2011 /PRNewswire-FirstCall/ -- Lockheed Martin Corporation (NYSE: LMT) has completed its acquisition of QTC Holdings Inc. The company, based in Diamond Bar, Calif., is the largest provider of outsourced medical evaluation services to the U.S. Department of Veterans Affairs (VA), processing more than 450,000 evaluations last year.

Founded in 1981, QTC provides IT-enabled case management services and health care expertise to the Department of Defense, the VA and other U.S. government agencies. The acquisition was originally announced on August 22, 2011. Terms of the transaction were not disclosed.

Headquartered in Bethesda, Md., Lockheed Martin is a global security company that employs about 126,000 people worldwide and is principally engaged in the research, design, development, manufacture, integration and sustainment of advanced technology systems, products and services. The Corporation reported 2010 sales from continuing operations were $45.8 billion.

For additional information, visit our website: http://www.lockheedmartin.com


'/>"/>
SOURCE Lockheed Martin
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Elsevier Appoints Martin OMalley as Managing Director of New Global Sales Group in Science & Technology Division
2. KLS Martins SonicWeld Rx Changing the Face of Craniomaxillofacial Plate Fixation
3. Josephine Martin Joins PhRMA as Exec VP of Public Affairs
4. Menicon Appoints Manuel Martin Chief Financial Officer for Europe
5. Millennium Laboratories Announces New General Counsel Martin Price and Chief Compliance Officer Janna Sipes
6. BioMedix™ Announces John Martin, MD, FACS, as Medical Director
7. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
8. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
11. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/9/2017)... ALTO, Calif. , June 9, 2017 ... device company focused on the design, manufacture, sale and ... the market on the progress of its commercial roll-out ... is now available in more than one hundred (100) ... AeroForm offers a needle-free alternative for ...
(Date:6/7/2017)... 7, 2017 Endo International plc (NASDAQ: ... the Hon. Joseph R. Goodwin , U.S. District ... West Virginia , entered a case management order ... System Products Liability Litigation (the "MDL") that includes a ... provide expert disclosures on specific causation within one hundred ...
(Date:6/3/2017)... 3, 2017  Eli Lilly and Company (NYSE: ... from the Phase 3 MONARCH 2 study showed ... inhibitor, in combination with fulvestrant, significantly improved progression-free ... in women with hormone-receptor-positive (HR+), human epidermal growth ... have relapsed or progressed after endocrine therapy (median ...
Breaking Medicine Technology:
(Date:6/28/2017)... ... June 28, 2017 , ... Schneider Insurance and ... to clients in southern Montana, is announcing a focused charity effort to gather ... outreach programs offered by Zoo Montana provide students with current knowledge on the ...
(Date:6/28/2017)... ... June 28, 2017 , ... ... servicing communities throughout the greater Cincinnati metropolitan area, is teaming up with the ... for families with children receiving treatment in nearby hospitals. , Ronald McDonald House ...
(Date:6/27/2017)... , ... June 27, 2017 , ... DrugDev ... is whether they can trust the sponsor to pay them correctly and on time. ... and CROs establish payment strategies that encourage sites to work on their studies. , ...
(Date:6/27/2017)... MA (PRWEB) , ... June 27, 2017 , ... The ... Senate bill to repeal and replace the 2010 Patient Protection and Affordable Care Act ... compared with what would be expected under current law. , More than 20 million ...
(Date:6/27/2017)... ... June 27, 2017 , ... A January 18th article on medGadget ... $6.81 billion by the year 2024 according to a new report. The article also ... made from titanium. Los Angeles area clinic Beverly Hills Periodontics & Dental Implant Center ...
Breaking Medicine News(10 mins):